Casana is a Rochester-based technology company that specializes in healthcare. It raised $30M through Series B funding.
Morningside led the round with Matrix Partners and other Series A investors, Outsiders Fund and General Catalyst.
The company plans to use the funds for FDA submission speeding of the Heart Seat. This will allow the company to achieve FDA approval and make this new device available to patients by 2022.
Casana was founded in 2018 by Dr. Nicholas Conn and is now led by Austin McChord as CEO. Casana offers healthcare technologies that allow integrated, in-home monitoring. Casana’s initial product, The Heart Seat(TM), is an IoT-health monitoring toilet seat that records clinically relevant data, such as heart rate, blood pressure and blood oxygenation.
The FDA approval for The Heart Seat is being sought by the company. Casana is also involved in numerous studies to determine the potential benefits of The Heart Seat for risk-bearing and health systems.